December 2009
HealthLeaders Magazine;Dec2009, Vol. 12 Issue 12, p28
The article features Guy M. Chisolm III, the person behind the initiative of Cleveland Clinic to disclose the financial relationship of physicians with drug and medical device companies. The initiative was launched in December 2008 and was developed when Cleveland Clinic hosted a conference of the Association of American Medical Colleges. Chisolm says that the reason he formed the initiative was because they were not ashamed of the great innovations and intellectual properties that they were able to develop from these relationships.


Related Articles

  • Wanna buy a doctor?  // Consumer Reports;Jun2012, Vol. 77 Issue 6, p6 

    The author discusses the influence of the drug and medical instrument industries on the decisions made by physicians, noting that the U.S. Institute of Medicine warns that their awarding of gifts, meals, or fees to doctors could cause conflicts of interest that threaten medical objectivity....

  • CONFLICTS. Cranin, A. Norman // Journal of Oral Implantology;2008, Vol. 34 Issue 5, p241 

    The author comments on the conflicts of interest in the health sector in the U.S. A report published in the May 10, 2006 issue of "New York Times" discusses the impact of the conflicting interests of doctors who were the recipients of grants from pharmaceutical and device manufacturers on...

  • In Defense of Industry-Physician Relationships. NAKAYAMA, DON K. // American Surgeon;Sep2010, Vol. 76 Issue 9, p987 

    The objective was to examine the economic, ethical, and legal foundations for conflict of interest restrictions between physicians and pharmaceutical and medical device industries ("industry"). Recently academic medical centers and professional organizations have adopted policies that restrict...

  • Pushing back the curtain. Rhea, Shawn // Modern Healthcare;12/8/2008, Vol. 38 Issue 49, p16 

    The article reports that Cleveland Clinic and the University of Pennsylvania School of Medicine and its health system, Penn Medicine, have announced plans to disclose consulting and research agreements that their physicians have with medical products companies. According to Patrick White, vice...

  • Shared Interests. Petersen, Carolyn // Pharmaceutical Executive;Aug2000, Vol. 20 Issue 8, p154 

    Comments on the disclosure of information on financial ties in the United States pharmaceutical industry. Demand for government research funding; Conflict of interest raised by the industry funding for trials; Overview of a case concerning the issue of whether the industry exerts undue...

  • Physicans band to stop conflicts of interest.  // Materials Management in Health Care;Mar2006, Vol. 15 Issue 3, p8 

    The article reports that a group of prominent physicians called for an end to doctors receiving gifts and other financial benefits from pharmaceutical and medical device companies. The group claims that the close relationships between physicians and manufacturers creates a conflict of interest...

  • Congress Proposes Reporting of Gifts to Docs. Wechsler, Jill // Pharmaceutical Executive;Apr2008, Vol. 28 Issue 4, p18 

    The article reports on the proposed legislation concerning pharma and medical devices makers in the U.S. The legislation, introduced by House and Senate leaders, will require pharma and medical devices makers to publicly disclose gifts or payments to physicians worth $25 or more. It will also...

  • Conflict-of-interest issues face increasing scrutiny.  // CMAJ: Canadian Medical Association Journal;11/17/98, Vol. 159 Issue 10, p1290 

    Discusses conflicts of interest in medical research in Canada. Changing rules on financial and scientific disclosure; Policy of the Royal College of Physicians and Surgeons of Canada; Need to report any conflict of interest prior to making a scientific presentation; Views of Allan Detsky,...

  • Supplements and conflicts of interest. Diniz, Juliana Belo; Bressan, Rodrigo A.; Miguel, Euripedes C.; Mari, Jair J.; Rohde, Luis Augusto; Mercadante, Marcos T.; Tavares, Hermano // Revista Brasileira de Psiquiatria;Dez2007, Vol. 29 Issue 4, p300 

    The article focuses on "Revista Brasileira de Psiquiatria" (RBP) journal and the issue regarding conflicts of interest. According to the authors, the RBP supplements have never been sponsored by one pharmaceutical industry. It says that RBP will conform to the new Medline rules which require...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics